文献速递中医内科中药与中成药合理使用

心可舒片通过多信号通路促进斑马鱼胚胎和人脐静脉内皮细胞血管生成

Xinkeshu tablets promote angiogenesis in zebrafish embryos and human umbilical vein endothelial cells through multiple signaling pathways.
PubMed 文献 · J Ethnopharmacol · 2023-05-12

本研究分析心可舒片甲醇提取物的化学成分,并在斑马鱼胚胎和人脐静脉内皮细胞(HUVEC)中评价其促血管生成作用及机制。共鉴定116种化学成分;心可舒片浓度依赖性地促进斑马鱼肠下血管丛生长并挽救PTK787诱导的节间血管损伤,同时挽救VRI损伤HUVEC的增殖、迁移和成管能力。转录组和qPCR提示其通过代谢、PPAR、AGE-RAGE、NOD样受体、VEGF及PI3K/Akt等多条信号通路调控血管生成。

要点

  • 心可舒片含116种化学成分,具有促血管生成潜力。
  • 在斑马鱼和HUVEC模型中均显示促血管生成作用。
  • 机制涉及PPAR、VEGF、PI3K/Akt等多条信号通路。

核心结论

  • 心可舒片可能通过多信号通路调控血管生成,从而用于冠心病治疗。

研究设计与样本

  • 研究采用UPLC-Q-Orbitrap-MS分析心可舒片甲醇提取物化学成分,并在斑马鱼胚胎和HUVEC中评价促血管生成作用,结合转录组和实时定量PCR探讨机制。

主要发现

  • 鉴定出心可舒片116种化学成分。
  • 心可舒片浓度依赖性地促进斑马鱼肠下血管丛生长并挽救PTK787诱导的节间血管损伤。
  • 心可舒片挽救VRI损伤HUVEC的增殖、迁移能力和成管作用。
  • 心可舒片通过代谢通路、PPAR信号通路、AGE-RAGE信号通路、NOD样受体信号通路、VEGF信号通路和PI3K/Akt信号通路促进血管生成。

临床怎么用

  • 心可舒片作为冠心病常用中成药,其促血管生成作用为临床用于缺血性心血管疾病提供了实验依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Angiogenesis is particularly important in ischemic cardiovascular diseases such as coronary heart disease (CHD). Xinkeshu tablets (XKS) are a commonly used Chinese patent medicine for CHD with a defined clinical effect. However, the proangiogenic effect of XKS remains unknown. AIM OF THE STUDY: We attempted to investigate the chemical composition and proangiogenic effect of XKS, as well as its underlying mechanisms. MATERIALS AND METHODS: The chemical composition of a XKS methanol extract was analyzed using a UPLC-Q-Orbitrap-MS system. The compound's proangiogenic effects were evaluated in zebrafish embryos and human umbilical vein endothelial cells (HUVECs). Furthermore, the underlying mechanisms were investigated using transcriptome assays and real-time quantitative PCR validation. RESULTS: We identified 116 chemical constituents of XKS. XKS significantly stimulated subintestinal vessel plexus (SIVs) growth and rescued tyrosine kinase inhibitor (PTK787)-induced intersegmental vessels (ISVs) injury in zebrafish in a concentration-dependent manner. XKS significantly rescued the proliferation, migration capacity and tube formation of Recombinant VEGFR tyrosine kinase inhibitor II (VRI)-injured HUVECs. XKS promoted angiogenesis through multiple signaling pathways, including metabolic pathways, the PPAR signaling pathway, the AGE-RAGE signaling pathway, the NOD-like receptor signaling pathway, the VEGF signaling pathway, and the PI3K/Akt signaling pathway. CONCLUSION: Herein, we identified 116 chemical constituents of XKS for the first time and demonstrated that XKS may regulate angiogenesis through multiple signaling pathways to treat CHD.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Liu Q, Zhang H, An Y, et al. Xinkeshu tablets promote angiogenesis in zebrafish embryos and human umbilical vein endothelial cells through multiple signaling pathways. J Ethnopharmacol. 2023. PMID: 37182673. doi:10.1016/j.jep.2023.116636

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。